Clin2
NCT06049680Possibly a fitRecruiting

Safety study of SMOFlipid for patients needing IV nutrition

Malnutrition, ChildMalnutritionEssential Fatty Acid Deficiency (EFAD)Parenteral Nutrition Associated Cholestasis

Part of Hormones & metabolism clinical trials.

This trial tests if SMOFlipid, a special lipid emulsion given through an IV, is safe for children and adults who need most of their nutrition from IV for at least 8 weeks. It looks for side effects like essential fatty acid deficiency or liver problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
1 month to 17 years
Study type
Interventional

Who can take part

  • You must be at least 1 month old
  • You need IV nutrition (PN) at least 5 days a week
  • At the start, you get 80% or more of your energy from IV nutrition, and expect to continue that for at least 56 days
  • You cannot have used other IV lipid emulsions besides SMOFlipid in the last 6 months
  • You must not have severe liver, kidney, blood, or metabolic problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06274788Recruiting
Safety study of long-term Omegaven for liver problems from IV nutrition

This study checks if children who need Omegaven for eight weeks or longer develop a lack of essential fats. It is for kids with liver issues caused by IV nutrition who cannot eat or digest food normally.

Fountain Valley, California
NCT06625372Recruiting
Comparing two IV nutrition options for children after stem cell transplant

This study compares two types of IV nutrition (Intralipid and SMOF Lipid) for children undergoing stem cell transplants for leukemia. It aims to find which option is better for helping them recover.

Tehran
NCT03530852Recruiting
RELIZORB test for children needing tube feeding and IV nutrition

This study tests whether RELIZORB helps children with short bowel syndrome (SBS), who rely on IV nutrition (and also tube feeding), absorb fats better. It is an open-label study over 90 days, meaning everyone gets the study treatment and outcomes are compared over time.

Los Angeles, California
NCT07752069Not yet recruiting· Phase 1
Comparing different versions of an experimental drug in healthy volunteers

This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.

Beijing, Beijing Municipality
NCT07210658Recruiting
Nutritional supplement tolerance study in children

This study is testing a new nutritional drink or powder to see if children like it, tolerate it well, and can stick with it. It replaces your child's current supplement with a new one, and researchers will check how it affects their digestion and overall health.

Nottingham
NCT04328337Recruiting· Phase 1/Phase 2
Study tests how rising fatty acids affect brain fuel use

This early-phase study will raise fatty acid levels temporarily and see how the brain uses glucose (sugar) and processes energy. It may help researchers understand how metabolism in the body can change brain function.

Chapel Hill, North Carolina

Hear when a new Malnutrition, Child trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.